LAVA Medtech Acquisition Corp. (LVACU) News
Filter LVACU News Items
LVACU News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest LVACU News From Around the Web
Below are the latest news stories about LAVA Medtech Acquisition Corp that investors may wish to consider to help them evaluate LVACU as an investment opportunity.
LAVA Medtech Acquisition Corp. Announces Closing of $115 Million Initial Public Offering Including Full Exercise of the Over-Allotment OptionWaltham, MA, Oct. 29, 2021 (GLOBE NEWSWIRE) -- LAVA Medtech Acquisition Corp. (the “Company”) today announced the closing of its initial public offering of 11,500,000 units at a price of $10.00 per unit, including 1,500,000 units pursuant to the full exercise of the underwriters’ over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $115,000,000. The Company’s units commenced trading on the Nasdaq Global Market (“Nasdaq”) on October 27, 2021, under the |
LAVA Medtech Acquisition Corp. Announces Pricing of $100 Million Initial Public OfferingWaltham, MA , Oct. 26, 2021 (GLOBE NEWSWIRE) -- LAVA Medtech Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading October 27, 2021, under the ticker symbol “LVACU.” Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant, each whole warrant entitling the holder thereof |